Brivaracetam: review of its pharmacology and potential use as adjunctive therapy in patients with partial onset seizures

Brivaracetam (BRV), a high-affinity synaptic vesicle protein 2A ligand, reported to be 10–30-fold more potent than levetiracetam (LEV), is highly effective in a wide range of experimental models of focal and generalized seizures. BRV and LEV similarly bind to synaptic vesicle protein 2A, while diffe...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Drug Des Devel Ther
Main Authors: Mumoli, Laura, Palleria, Caterina, Gasparini, Sara, Citraro, Rita, Labate, Angelo, Ferlazzo, Edoardo, Gambardella, Antonio, De Sarro, Giovambattista, Russo, Emilio
Format: Artigo
Sprog:Inglês
Udgivet: Dove Medical Press 2015
Fag:
Review
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4622453/
https://ncbi.nlm.nih.gov/pubmed/26543353
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S81474
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker